More children are testing positive for the flu as Californians continue to cough, hack and wheeze their way through an explosive influenza season. Influenza's rate of spread "is elevated in California ...

What do you do with a film that is so bloody, anarchic, and politically incorrect that test viewers leave the cinema in droves and the legal departments of major studios develop toxic stress bumps?

LITTLE ROCK, Ark. (KATV) — It’s a question so many women have asked: "If my mother had breast cancer, will I get it too?" But doctors say knowledge is power, and that power could save your life. UAMS ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

—Dr. McArthur of University of Texas Southwestern Medical School discusses the ideal time to pursue genomic testing and how it may be able to help guide treatment. (1:45) The Current and Future Roles ...

Children born to women who carry pathogenic variants in mitochondrial DNA (mtDNA) are at risk for a range of clinical syndromes collectively known as mtDNA disease. Mitochondrial donation by ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...